Novo is ready to invest billions in 2013
"We smell blood," says the CFO of Novo A/S following a highly lucrative investment in Chr. Hansen. The Novo group expects bigger investments in 2013 than in 2012.
by Henrik Tüchsen
The investment company Novo A/S, parent company to Novo Nordisk and Novozymes, is ready to spend big money again following a successful investment in the bio-industrial group Chr. Hansen. According to CFO Thorkil K. Christensen the company is ready to invest billions if the right offer comes along.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
